Outcomes by time frame
- !5 months
- "at 1 mounth"
- "at 7 weeks"
- "Change from baseline in suicide behavior at 6 months after the end of the intervention" and "Change from baseline in suicide behavior at 18 months after the end of intervention"
- "Change from baseline in suicide knowledge at 6 months after the end of the intervention" and "Change from baseline in suicide knowledge at 18 months after the end of intervention"
- "up to 36 weeks"
- % change from Baseline to Week 12
- % change from Visit 5 (C2, Day 1) to Visit 7 (C2, Day 15) in QOL index scores
- % change from Visit 5 (C2, Day 1) to Visit 7 (C2, Day 15) in WBC
- % change from Visit 5 (C2, Day 1) to Visit 7 (C2, Day 15) in WBC,
- % change in NAPSI score at Week 12 vs placebo in subjects with nail psoriasis
- % change in tumour size at 8 weeks
- % epithelialization assessed post-debridement at weekly intervals until all a patient's wounds closed
- % of exact responses
- % of patients progression -free at 6 months
- > 6 months
- > Day 120
- ''Baseline PSG night'' and ''pure prone positioning night within two weeks of baseline PSG night''
- ( Day 0 to 12 months or in case of premature withdrawal after 6 months period
- (0-12 weeks)
